Cargando…
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
BACKGROUND: Relatively little is known about the stability of a diagnosis of episodic migraine (EM) or chronic migraine (CM) over time. This study examines natural fluctuations in self-reported headache frequency as well as the stability and variation in migraine type among individuals meeting crite...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628086/ https://www.ncbi.nlm.nih.gov/pubmed/28980171 http://dx.doi.org/10.1186/s10194-017-0787-1 |
_version_ | 1783268821122940928 |
---|---|
author | Serrano, Daniel Lipton, Richard B. Scher, Ann I. Reed, Michael L. Stewart, Walter (Buzz) F. Adams, Aubrey Manack Buse, Dawn C. |
author_facet | Serrano, Daniel Lipton, Richard B. Scher, Ann I. Reed, Michael L. Stewart, Walter (Buzz) F. Adams, Aubrey Manack Buse, Dawn C. |
author_sort | Serrano, Daniel |
collection | PubMed |
description | BACKGROUND: Relatively little is known about the stability of a diagnosis of episodic migraine (EM) or chronic migraine (CM) over time. This study examines natural fluctuations in self-reported headache frequency as well as the stability and variation in migraine type among individuals meeting criteria for EM and CM at baseline. METHODS: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study was a longitudinal survey of US adults with EM and CM identified by a web-questionnaire. A validated questionnaire was used to classify respondents with EM (<15 headache days/month) or CM (≥15 headache days/month) every three months for a total of five assessments. We described longitudinal persistence of baseline EM and CM classifications. In addition, we modelled longitudinal variation in headache day frequency per month using negative binomial repeated measures regression models (NBRMR). RESULTS: Among the 5464 respondents with EM at baseline providing four or five waves of data, 5048 (92.4%) had EM in all waves and 416 (7.6%) had CM in at least one wave. Among 526 respondents with CM at baseline providing four or five waves of data, 140 (26.6%) had CM in every wave and 386 (73.4%) had EM for at least one wave. Individual plots revealed striking within-person variations in headache days per month. The NBRMR model revealed that the rate of headache days increased across waves of observation 19% more per wave for CM compared to EM (rate ratio [RR], 1.19; 95% CI, 1.13–1.26). After adjustment for covariates, the relative difference changed to a 26% increase per wave (RR, 1.26; 95% CI, 1.2–1.33). CONCLUSIONS: Follow-up at three-month intervals reveals a high level of short-term variability in headache days per month. As a consequence, many individuals cross the CM diagnostic boundary of ≥15 headache days per month.Nearly three quarters of persons with CM at baseline drop below this diagnostic boundary at least once over the course of a year. These findings are of interest in the consideration of headache classification and diagnosis, the design and interpretation of epidemiologic and clinical studies, and clinical management. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s10194-017-0787-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5628086 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-56280862017-10-17 Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design Serrano, Daniel Lipton, Richard B. Scher, Ann I. Reed, Michael L. Stewart, Walter (Buzz) F. Adams, Aubrey Manack Buse, Dawn C. J Headache Pain Research Article BACKGROUND: Relatively little is known about the stability of a diagnosis of episodic migraine (EM) or chronic migraine (CM) over time. This study examines natural fluctuations in self-reported headache frequency as well as the stability and variation in migraine type among individuals meeting criteria for EM and CM at baseline. METHODS: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study was a longitudinal survey of US adults with EM and CM identified by a web-questionnaire. A validated questionnaire was used to classify respondents with EM (<15 headache days/month) or CM (≥15 headache days/month) every three months for a total of five assessments. We described longitudinal persistence of baseline EM and CM classifications. In addition, we modelled longitudinal variation in headache day frequency per month using negative binomial repeated measures regression models (NBRMR). RESULTS: Among the 5464 respondents with EM at baseline providing four or five waves of data, 5048 (92.4%) had EM in all waves and 416 (7.6%) had CM in at least one wave. Among 526 respondents with CM at baseline providing four or five waves of data, 140 (26.6%) had CM in every wave and 386 (73.4%) had EM for at least one wave. Individual plots revealed striking within-person variations in headache days per month. The NBRMR model revealed that the rate of headache days increased across waves of observation 19% more per wave for CM compared to EM (rate ratio [RR], 1.19; 95% CI, 1.13–1.26). After adjustment for covariates, the relative difference changed to a 26% increase per wave (RR, 1.26; 95% CI, 1.2–1.33). CONCLUSIONS: Follow-up at three-month intervals reveals a high level of short-term variability in headache days per month. As a consequence, many individuals cross the CM diagnostic boundary of ≥15 headache days per month.Nearly three quarters of persons with CM at baseline drop below this diagnostic boundary at least once over the course of a year. These findings are of interest in the consideration of headache classification and diagnosis, the design and interpretation of epidemiologic and clinical studies, and clinical management. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s10194-017-0787-1) contains supplementary material, which is available to authorized users. Springer Milan 2017-10-04 /pmc/articles/PMC5628086/ /pubmed/28980171 http://dx.doi.org/10.1186/s10194-017-0787-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Article Serrano, Daniel Lipton, Richard B. Scher, Ann I. Reed, Michael L. Stewart, Walter (Buzz) F. Adams, Aubrey Manack Buse, Dawn C. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
title | Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
title_full | Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
title_fullStr | Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
title_full_unstemmed | Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
title_short | Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
title_sort | fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628086/ https://www.ncbi.nlm.nih.gov/pubmed/28980171 http://dx.doi.org/10.1186/s10194-017-0787-1 |
work_keys_str_mv | AT serranodaniel fluctuationsinepisodicandchronicmigrainestatusoverthecourseof1yearimplicationsfordiagnosistreatmentandclinicaltrialdesign AT liptonrichardb fluctuationsinepisodicandchronicmigrainestatusoverthecourseof1yearimplicationsfordiagnosistreatmentandclinicaltrialdesign AT scheranni fluctuationsinepisodicandchronicmigrainestatusoverthecourseof1yearimplicationsfordiagnosistreatmentandclinicaltrialdesign AT reedmichaell fluctuationsinepisodicandchronicmigrainestatusoverthecourseof1yearimplicationsfordiagnosistreatmentandclinicaltrialdesign AT stewartwalterbuzzf fluctuationsinepisodicandchronicmigrainestatusoverthecourseof1yearimplicationsfordiagnosistreatmentandclinicaltrialdesign AT adamsaubreymanack fluctuationsinepisodicandchronicmigrainestatusoverthecourseof1yearimplicationsfordiagnosistreatmentandclinicaltrialdesign AT busedawnc fluctuationsinepisodicandchronicmigrainestatusoverthecourseof1yearimplicationsfordiagnosistreatmentandclinicaltrialdesign |